Colorectal cancer (CRC) remains the third most common cancer and cancer-related death in US women and men. Although the totality of evidence in aggregate supports a beneficial role of calcium in colorectal carcinogenesis, three major unresolved outstanding questions exist. First, the optimal dose and timing of calcium intake for CRC prevention remains unknown. Second, although several proposed mechanisms for calcium's role in risk may also influence cancer progression, no study has yet examined whether post-diagnostic calcium intake will improve survival among CRC patients. Lastly, the biological pathways by which calcium influences CRC risk remain unknown. Because future randomized controlled trials may not be feasible to test different doses with long or unknown latency between start intervention and CRC onset, we propose to examine the following specific aims using the resources of two large, well- characterized cohorts of women (the Nurses'Health Study, NHS) and men (the Health Professionals Follow-up Study, HPFS), in which calcium intake was assessed every 4 years since 1980 and 1986 respectively, using validated food frequency questionnaires. With up to 3 decades of follow-up, long-term effects can be studied.
Aim 1 is to investigate the optimal dose and timing of calcium intake for CRC prevention.
Aim 2 is to assess whether adequate post- diagnostic calcium intake is associated with better CRC survival.
Aim 3 is to discover biological pathways through which calcium might operate to reduce risk of CRC using pre-existing mRNA expression data from the CRC tumors. Two large cohort studies of women and men with multiple calcium assessments and pre-existing validated mRNA expression data provide a unique opportunity to address the proposed aims in a cost-effective manner. Completion of this project will make important contributions towards informing future dietary recommendations of calcium intake for CRC prevention and survival in US adults.

Public Health Relevance

To bridge the gap in our knowledge with regard to calcium intake for colorectal cancer prevention, we propose the first comprehensive evaluation of the optimal dose and timing of calcium intake using the resources of two large, well-characterized cohorts of women (the Nurses'Health Study) and men (the Health Professionals Follow-up Study). Although several proposed mechanisms for calcium's role in risk may also influence cancer progression, no study has yet examined whether post-diagnostic calcium intake will improve survival among CRC patients and we thus propose the first evaluation of calcium and CRC survival. We further propose a novel discovery approach identifying unique differences in mRNA expression to determine the potential biological pathways through which calcium may operate to reduce CRC risk. Completion of this project will make important contributions towards informing future dietary recommendations of calcium intake for CRC prevention and survival in US adults.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
1R03CA176717-01A1
Application #
8636575
Study Section
Special Emphasis Panel (ZCA1-SRLB-D (O1))
Program Officer
Su, Joseph
Project Start
2014-06-01
Project End
2016-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
1
Fiscal Year
2014
Total Cost
$88,416
Indirect Cost
$38,416
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115